U.S. Glucagon Delivery Devices Market Share To Reach Scalable Heights Of Growth
U.S. Glucagon Delivery Devices Market Summary The U.S. glucagon delivery devices market size was estimated at USD 446.98 million in 2023 and is projected to grow at a CAGR of 8.33% from 2024 to 2030. There are several factors contributing to the market growth in the U.S., which include the growing prevalence of diabetes in the country, the development of advanced and user-friendly delivery devices, aging population, and increasing awareness about advantages of glucagon among patients and healthcare professionals. According to the American Diabetes Association, around 38.4 million people in the U.S., accounting for around 11.6% of the population, had diabetes in 2021. Moreover, around 1.2 million people in the country are diagnosed with diabetes every year. As the number of individuals diagnosed with diabetes continues to increase, the incidence of hypoglycemia, a condition in which blood glucose levels drop, is also anticipated to rise. This condition is especially co...